本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Corcept医疗

69.27
+4.597.10%
盘后70.611.34+1.93%16:29 EDT
成交量:179.50万
成交额:1.24亿
市值:73.08亿
市盈率:56.32
高:70.73
开:66.78
低:65.77
收:64.68
数据加载中...
2024/05/23

重要事件披露

Form 8-K - Current report
2024/05/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/01

重要事件披露

Form 8-K - Current report
2024/05/01

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/17

重要事件披露

Form 8-K - Current report
2024/04/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/15

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/15

重要事件披露

Form 8-K - Current report
2024/02/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/12

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/08

重要事件披露

Form 8-K - Current report